ProForma 2.0
Not calculated for this record
RV-23
Aliases: pep_RV23, RV-23
Normalized sequence
RIGVLLARLPKLFSLFKLMGKKV
23 amino acids
Release PepDiana-V1-20260620
31
Activity records
2
Source papers
27
Positive
4
Negative / threshold
Cross-layer links
Versioned scientific descriptors
No separate physicochemical property was reported in the primary-literature identity record. PepDiana release values are shown as computed properties.
Molecular weight
Not calculated
Molecular formula
Not calculated
Theoretical pI
Not calculated
Net charge at pH 7
Not calculated
GRAVY
Not calculated
Instability index
Not calculated
Aromaticity
Not calculated
Topological polar surface area
Not calculated
cLogP
Not calculated
Hydrogen-bond donors
Not calculated
Hydrogen-bond acceptors
Not calculated
Rotatable bonds
Not calculated
Method: Not recorded
Tool: Not recorded
Calculated: Not recorded
ProForma 2.0
Not calculated for this record
HELM 2.0
Not calculated for this record
Canonical SMILES
Not calculated for this record
Isomeric SMILES
Not calculated for this record
Paper-level observations
Table 1: RV-23 MIC 6.25 μM against K. pneumoniae ATCC 10031.
Table 1: RV-23 MBC 12.5 μM against K. pneumoniae ATCC 10031.
Table 1: RV-23 MIC 12.5 μM against E. coli ATCC 25992.
Table 1: RV-23 MBC 12.5 μM against E. coli ATCC 25992.
Table 2: RV-23 MIC 12.5 μM against K. pneumoniae 1711.
Table 2: RV-23 MBC 12.5 μM against K. pneumoniae 1711.
Table 2: RV-23 MIC 50 μM against K. pneumoniae 311.
Table 2: RV-23 MBC 50 μM against K. pneumoniae 311.
Table 2: RV-23 MIC 12.5 μM against K. pneumoniae 1745.
Table 2: RV-23 MBC 25 μM against K. pneumoniae 1745.
Table 2: RV-23 MIC 12.5 μM against K. pneumoniae 1746.
Table 2: RV-23 MBC N/D against K. pneumoniae 1746.
Table 2: RV-23 MIC 12.5 μM against E. coli 2267.
Table 2: RV-23 MBC 12.5 μM against E. coli 2267.
Table 2: RV-23 MIC 25 μM against E. coli 3140.
Table 2: RV-23 MBC N/D against E. coli 3140.
Table 2: RV-23 MIC 25 μM against E. coli 716.
Table 2: RV-23 MBC 25 μM against E. coli 716.
Table 2: RV-23 MIC 6.25 μM against E. coli 1376.
Table 2: RV-23 MBC 6.25 μM against E. coli 1376.
Table 2: RV-23 MIC 6.25 μM against E. coli 1441.
Table 2: RV-23 MBC 12.5 μM against E. coli 1441.
RV-23 causes a total reduction in biofilm attachment at 50 and 12.5 μM for K. pneumoniae and E. coli, respectively.
RV-23 causes a total reduction in biofilm attachment at 50 and 12.5 μM for K. pneumoniae and E. coli, respectively.
According to the best antimicrobial activity evidenced for RV-23, its combination with meropenem provides the best results, with a MIC at 3.125 μM (peptide) and 0.625 μg/mL (antibiotic) against K. pneumoniae.
According to the best antimicrobial activity evidenced for RV-23, its combination with meropenem provides the best results, with a MIC at ... 6.25 μM (peptide) and 2.5 μg/mL (antibiotic) against E. coli.
RV-23 was found to be more active than AR-23, with an inhibitory concentration of 50% (IC50) at 10 μM ... in co-treatment.
RV-23 ... IC50 at ... 6.25 μM ... in virus pre-treatment assays.
On the contrary, no activity was observed after the viral adsorption step (post-treatment), indicating that the peptides did not interfere later in the infection.
RV-23 was not cytotoxic up to the highest dose (50 μM). Figure 1 shows cell viability at 50–3.125 μM.
Hylin-a1 and RV-23 have lower toxicity with a 50% cytotoxic concentration (CC50) of 100 μM.
Citation and release provenance
Cite this identity as PepDiana record PEPDIA-PLP-003969, release PepDiana-V1-20260620. Experimental observations retain their paper, mention, and activity-record identifiers.
Record updated: 2026-06-22T07:14:26.229247+00:00